Your shopping cart is currently empty

Ro 15-2041, a selective inhibitor of platelet phosphodiesterase, exhibits notable antithrombotic properties.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $1,670 | 6-8 weeks | 6-8 weeks | |
| 50 mg | $2,180 | 6-8 weeks | 6-8 weeks | |
| 100 mg | $2,800 | 6-8 weeks | 6-8 weeks |
| Description | Ro 15-2041, a selective inhibitor of platelet phosphodiesterase, exhibits notable antithrombotic properties. |
| In vitro | Ro 15-2041 inhibits platelet aggregation induced by common agonists in platelet-rich plasma from various species, including humans, with an IC50 of 1-3 μM. It enhances prostacyclin-induced platelet inhibition, increases (c) AMP levels, and inhibits collagen-induced release of serotonin and beta-thromboglobulin. It also reduces and normalizes cytosolic free Ca2+ levels in thrombin-stimulated human platelets. Ro 15-2041 is a potent (IC50 = 70 nM) and selective inhibitor of platelet cAMP-phosphodiesterase activity. |
| Molecular Weight | 294.15 |
| Formula | C12H12BrN3O |
| Cas No. | 77448-87-4 |
| Smiles | CC1N2C(NC=3C(C2)=C(C)C(Br)=CC3)=NC1=O |
| Relative Density. | no data available |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.